The Adverse Outcome Pathway Framework Applied to Neurological Symptoms of COVID-19
- PMID: 36359807
- PMCID: PMC9658029
- DOI: 10.3390/cells11213411
The Adverse Outcome Pathway Framework Applied to Neurological Symptoms of COVID-19
Abstract
Several reports have shown that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has the potential to also be neurotropic. However, the mechanisms by which SARS-CoV-2 induces neurologic injury, including neurological and/or psychological symptoms, remain unclear. In this review, the available knowledge on the neurobiological mechanisms underlying COVID-19 was organized using the AOP framework. Four AOPs leading to neurological adverse outcomes (AO), anosmia, encephalitis, stroke, and seizure, were developed. Biological key events (KEs) identified to induce these AOs included binding to ACE2, blood-brain barrier (BBB) disruption, hypoxia, neuroinflammation, and oxidative stress. The modularity of AOPs allows the construction of AOP networks to visualize core pathways and recognize neuroinflammation and BBB disruption as shared mechanisms. Furthermore, the impact on the neurological AOPs of COVID-19 by modulating and multiscale factors such as age, psychological stress, nutrition, poverty, and food insecurity was discussed. Organizing the existing knowledge along an AOP framework can represent a valuable tool to understand disease mechanisms and identify data gaps and potentially contribute to treatment, and prevention. This AOP-aligned approach also facilitates synergy between experts from different backgrounds, while the fast-evolving and disruptive nature of COVID-19 emphasizes the need for interdisciplinarity and cross-community research.
Keywords: AOP; SARS-CoV-2; anosmia; encephalitis; human-specific research; neuropathology; stroke.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
-
COVID-19 through Adverse Outcome Pathways: Building networks to better understand the disease - 3rd CIAO AOP Design Workshop.ALTEX. 2022;39(2):322–335. doi: 10.14573/altex.2112161. Epub 2022 Jan 3. ALTEX. 2022. PMID: 35032963 Free PMC article.
-
Mechanistic Understanding of the Olfactory Neuroepithelium Involvement Leading to Short-Term Anosmia in COVID-19 Using the Adverse Outcome Pathway Framework.Cells. 2022 Sep 27;11(19):3027. doi: 10.3390/cells11193027. Cells. 2022. PMID: 36230989 Free PMC article. Review.
-
Understanding COVID-19 through adverse outcome pathways - 2nd CIAO AOP Design Workshop.ALTEX. 2021;38(2):351-357. doi: 10.14573/altex.2102221. Epub 2021 Mar 5. ALTEX. 2021. PMID: 33677612
-
Neurological Sequelae of COVID-19.J Integr Neurosci. 2022 Apr 6;21(3):77. doi: 10.31083/j.jin2103077. J Integr Neurosci. 2022. PMID: 35633158 Review.
-
Beyond chemicals: Opportunities and challenges of integrating non-chemical stressors in adverse outcome pathways.ALTEX. 2024;41(2):233-247. doi: 10.14573/altex.2307061. Epub 2023 Nov 17. ALTEX. 2024. PMID: 37980615
Cited by
-
CIAO: a living experiment in interdisciplinary large-scale collaboration facilitated by the Adverse Outcome Pathway framework.Front Public Health. 2023 Aug 10;11:1212544. doi: 10.3389/fpubh.2023.1212544. eCollection 2023. Front Public Health. 2023. PMID: 37637826 Free PMC article.
-
Influence of SARS-CoV-2 on Adult Human Neurogenesis.Cells. 2023 Jan 6;12(2):244. doi: 10.3390/cells12020244. Cells. 2023. PMID: 36672177 Free PMC article.
-
Oxidative stress and COVID-19-associated neuronal dysfunction: mechanisms and therapeutic implications.Acta Biochim Biophys Sin (Shanghai). 2023 Jun 25;55(8):1153-1167. doi: 10.3724/abbs.2023085. Acta Biochim Biophys Sin (Shanghai). 2023. PMID: 37357527 Free PMC article. Review.
-
Building an Adverse Outcome Pathway network for COVID-19.Front Syst Biol. 2024 Jun 6;4:1384481. doi: 10.3389/fsysb.2024.1384481. Front Syst Biol. 2024. PMID: 40206642 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous